Estrogen suppresses metastasis in rat hepatocellular carcinoma through decreasing interleukin-6 and hepatocyte growth factor expression

Inflammation

Volumn 35, Issue 1, 2012, Pages 143-149

  Wang, Yong Cang ^a   Xu, Ge Liang ^a   Jia, Wei Dong ^a   Han, Sheng Jin ^a   Ren, Wei Hua ^a   Wang, Wei ^a   Liu, Wen Bin ^a   Zhang, Chuan Hai ^a   Chen, Hao ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Estrogen; Hepatocellular carcinoma; Hepatocyte growth factor; Interleukin 6; Metastasis

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ETHINYLESTRADIOL; INTERLEUKIN 6; SCATTER FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER MODEL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; IN VIVO STUDY; LIVER CELL CARCINOMA; LUNG METASTASIS; METASTASIS INHIBITION; NONHUMAN; OVARIECTOMY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; TUMOR MICROENVIRONMENT;

ANIMALS; CARCINOMA, HEPATOCELLULAR; DIETHYLNITROSAMINE; ESTROGENS; ETHINYL ESTRADIOL; FEMALE; HEPATOCYTE GROWTH FACTOR; INTERLEUKIN-6; LIVER NEOPLASMS, EXPERIMENTAL; LUNG NEOPLASMS; NITROSAMINES; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; TUMOR MICROENVIRONMENT;

RATTUS;

EID: 84859429709     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-011-9299-3     Document Type: Article

References (14)

1. El-Serag, H.B., and K.L. Rudolph. 2007. Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576. (Pubitemid 46890874)
2. Naugler, W.E., T. Sakurai, S. Kim, S. Maeda, K. Kim, A.M. Elsharkawy, et al. 2007. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317: 121-124. (Pubitemid 47056470)
3. Shimizu, I., M. Yasuda, Y. Mizobuchi, Y.R. Ma, F. Liu, M. Shiba, et al. 1998. Suppressive effect of oestradiol on chemical hepatocarcinogenesis in rats. Gut 42: 112-119. (Pubitemid 28228398)
4. Coussens, L.M., and Z. Werb. 2002. Inflammation and cancer. Nature 420: 860-867. (Pubitemid 36019639)
5. Karin, M. 2006. Nuclear factor-kappaB in cancer development and progression. Nature 441: 431-436. (Pubitemid 44050137)
6. Wang, W., W.D. Jia, G.L. Xu, Z.H. Wang, J.S. Li, J.L. Ma, et al. 2009. Antitumoral activity of rapamycin mediated through inhibition of HIF-1alpha and VEGF in hepatocellular carcinoma. Digestive Diseases and Sciences 54: 2128-2136.
7. Ke, H.Z., H.K. Chen, H.A. Simmons, H. Qi, D.T. Crawford, C.M. Pirie, et al. 1997. Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model. Bone 20: 31-39. (Pubitemid 27046637)
8. Moon, W.S., K. Chang, and A.S. Tarnawski. 2004. Overexpression of metastatic tumor antigen 1 in hepatocellular carcinoma: Relationship to vascular invasion and estrogen receptor-alpha. Human Pathology 35: 424-429. (Pubitemid 38507078)
9. Soresi, M., L. Giannitrapani, F. D'Antona, A.M. Florena, E. La Spada, A. Terranova, et al. 2006. Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma. World Journal of Gastroenterology 12: 2563-2568.
10. Yamaguchi, Y. 2007. Microenvironmental regulation of estrogen signals in breast cancer. Breast Cancer 14: 175-181.
11. Porter, L.E., M.S. Elm, D.H. Van Thiel, M.C. Dugas, and P.K. Eagon. 1983. Characterization and quantitation of human hepatic estrogen receptor. Gastroenterology 84: 704-712. (Pubitemid 13152615)
12. Eagon, P.K., S.E. Fisher, A.F. Imhoff, L.E. Porter, R.R. Stewart, D. H. Van Thiel, et al. 1980. Estrogen-binding proteins of male rat liver: Influences of hormonal changes. Archives of Biochemistry and Biophysics 201: 486-499. (Pubitemid 11140684)
13. Shimizu, I., and S. Ito. 2007. Protection of estrogens against the progression of chronic liver disease. Hepatology Research 37: 239-247. (Pubitemid 46505837)
14. Itagaki, T., I. Shimizu, X. Cheng, Y. Yuan, A. Oshio, K. Tamaki, et al. 2005. Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells. Gut 54: 1782-1789. (Pubitemid 41697679)